Great Britain Medicines

Much of the fundamental work on prostaglandins and related compounds was car ried out by Sune Bergstrom and Bengt Samuelsson of the Karohnska Institute (Sweden) and by Sir John Vane of the Wellcome Foundation (Great Britain) These three shared the Nobel Prize for physiology or medicine m 1982... 

Aikens JE, Nease Jr DE et aL (2005) Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 3 23-30 Blenkinsopp A, Bond C, Britten N (1997) From compliance to concordance. Achieving shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain and Merck Sharpe Dome, London UK... 

Royal Pharmaceutical Society (1997) From compliance to concordance towards shared goals in medicine taking. Royal Pharmaceutical Society of Great Britain, London... 

In ancient times, poison-hemlock seed was collected green, dried and stored to be used medicinally as a sedative. The dried leaf and juice of Conium maculatum L. (Hemlock) were listed in pharmacopoeias of London and Edinburgh from 1864 to 1898, and the last official record appeared in Great Britain in the British Pharmaceutical Codex of 1934. Interest in the medicinal value of poison-hemlock has declined because of the unpredictability of its effects. The unpredictability is now understood, the toxin profile and concentration in the plant and green seed can vary dramatically because of environmental factors or, even, diurnally. 

Snell M, ed (2008). Medicines, Ethics and Practice a guide for pharmacists and pharmacy technicians, 32nd rev edn. London Royal Pharmaceutical Society of Great Britain. Sweetman SC, ed (2006). Martindale the Complete Drug Reference, 35th edn. London Pharmaceutical Press. 

Medicines, Ethics and Practice a Guide for Pharmacists and Pharmacy Technicians, 32, July 2008. London Royal Pharmaceutical Society of Great Britain, 2008. 

The Proprietary Association of Great Britain. Code o/ Standards of Advertising Practice for Over-the-Counter Medicines. London PAGB, 1986. 

The promotion of medicines to the general public for self medication is covered by the Code of Standards of Advertising Practice for Over-the-Counter Medicines of the Proprietary Association of Great Britain (PAGE). The PAGE also has a Code of Practice for Advertising Over-the-Counter Medicines to Health Professionals and the Retail Trade. 

Methods of sale of medicines through pharmacies are also covered by the Code of Ethics of the Royal Pharmaceutical Society of Great Britain. 

Copies of the published reports are sent to the Medicines and Healthcare products Regulatory Agency, the Office of Fair Trading, the British Medical Association, the Royal Pharmaceutical Society of Great Britain and the Editors of the BMJ and The Pharmaceutical Journal. Copies of the published reports are also available to anyone on request. 

Code of Practice for Advertising Over-the-Counter Medicines to Health Professionals and the Retail Trade (Proprietary Association of Great Britain - PAGB)... 

Professor David Michael P. Mingos, Imperial College of Science, Technology and Medicine, Dept, of Chemistry, South Kensington, London SW7 2AY, Great Britain... 

One of the developments that has contributed substantially to the improved quality of drug development is the emergence of Pharmaceutical Medicine. Pharmaceutical Medicine is the discipline concerned with the medical aspects of research, development, evaluation, registration, monitoring and marketing of medicines in the interest of patients. In Great Britain a Diploma in Pharmaceutical Medicine was introduced in 1975, and in 1989 the Faculty of Pharmaceutical Medicine was established as part of the Royal College of Physicians. Subsequently, similar developments took place in other countries. 

The sale of amyl nitrite is illegal in Great Britain without a prescription. But the possession or use without a prescription is not illegal. In New Zealand, amyl and butyl nitrites are controlled under the Medicines Act of 1981. This Act limits the availability of substances that can be used as medicines and imposes penalties for misuse of these drugs. Penalties can be up to three months in jail, a fine of 500, or both. Police also can hold people under the influence of the drug for detoxification under the Alcoholism and Drug Addiction Act 1966. This is rarely done, since the visible effects of amyl nitrite use usually wear off after a few minutes. 

In Great Britain, the Medicines Act deems it illegal to sell amyl nitrite without a prescription. However, possession or use without a prescription is not a crime. Most other nitrates sold as poppers have escaped prosecution under the Medicines Act since distributors claimed they were room deodorizers and not marketed as medicine. However, the European Union (EU), of which Great Britain is a member, has issued a directive that any substance for sale that has a mood-altering or psychoactive effect can be classified as a medicine even if it is not labeled or marketed as such. The Medicines Control Agency, which administers the Medicines Act, has concurred with the EU directive, although as of early 2002, there was no move to control or ban poppers. 

Great Britain regulates 2C-B under the Medicines Act. A conviction for possession of the drug carries an average sentence of two years and two months in prison and a fine of about 185. The maximum sentence is seven years in prison and an unlimited fine. The maximum penalty for selling 2C-B is life in prison and an unlimited fine. 

In Great Britain, all SSRI antidepressants, except fluoxetine, have been banned for use in treating depression in children. The main concern surrounded suicidality that was increased with SSRIs in general, including fluoxetine (Committee on Safety of Medicines, 2003). 

Great Britain s Committee on Safety of Medicines (CSM 1988) recommended that benzodiazepines should not be used alone to treat depression or anxiety associated with depression. Suicide may be precipitated in such patients. ... 

Royal Pharmaceutical Society of Great Britain (RPSGB) (2007) Fitness to Practice and Legal Affairs Directorate Fact Sheet Five. The use of unlicensed medicines in pharmacy. http //www.rpsgb.org/pdfs/factsheet5. pdf [Accessed 4 July 2008],... 

The United States Congress has seen fit to grant patents on new chemical substances, regardless of how they are made. A few major industrial countries follow suit, some with limitations as to the field of use. Examples are Great Britain, France, Canada (except foods and medicines), Australia, South Africa, India, and Pakistan. But most countries limit patent protection to processes. Germany and most other European countries are examples. Thus, it may be advisable to patent as many processes as possible leading to a desired end product. 

Glycerites Glycerites are solutions of medicinal substances in glycerin introduced in the 5th revision of the United States Pharmacopoeia (1873). Glycerites afford a rapid and simple method of making aqueous solutions of phenol, tannic acid, tar, and other substances that are not otherwise easily soluble. This class of preparations is called glycerins in Great Britain. " ... 

The Pharmaceutical Society of Great Britain, Department of Pharmaceutical Sciences. Plastic medicine bottles of rigid PVG. Pharm J 1973 210 100. 

Medicines Control Agency, with the industry usually via the offices of the main representative trade associations such as the Association of the British Pharmaceutical Industry (ABPI) and the Proprietary Association of Great Britain (PAGB), and with many other interested organisations and individuals. 

The Association of the British Pharmaceutical Industry in consultation with the British Medical Association, the Royal Pharmaceuticcd Society of Great Britain, and the Medicines Control Agency, has drawn up a Code of Practice for the Phar-maceuticcil Industry this code applies to the promotion of medicines to the health professions and controls advertisements designed to encourage the prescribing... 

---